Asensus Surgical (NYSEAMERICAN:ASXC) Trading Up 3.3%

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) shares traded up 3.3% during trading on Friday . The company traded as high as $0.25 and last traded at $0.25. 605,332 shares were traded during trading, a decline of 60% from the average session volume of 1,528,514 shares. The stock had previously closed at $0.24.

Analysts Set New Price Targets

Separately, HC Wainwright downgraded Asensus Surgical from a “buy” rating to a “neutral” rating and cut their target price for the stock from $2.00 to $0.35 in a research note on Thursday, April 4th.

Asensus Surgical Stock Performance

The firm has a market capitalization of $67.73 million, a price-to-earnings ratio of -0.78 and a beta of 1.43.

Asensus Surgical (NYSEAMERICAN:ASXC) last released its quarterly earnings results on Thursday, March 21st. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The firm had revenue of $5.43 million during the quarter. Asensus Surgical had a negative return on equity of 135.94% and a negative net margin of 914.46%. As a group, equities analysts predict that Asensus Surgical, Inc. will post -0.19 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Asensus Surgical stock. Avantax Planning Partners Inc. boosted its position in Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 773.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 112,936 shares of the company’s stock after acquiring an additional 100,000 shares during the quarter. Avantax Planning Partners Inc.’s holdings in Asensus Surgical were worth $30,000 as of its most recent filing with the Securities & Exchange Commission. 9.35% of the stock is owned by institutional investors.

About Asensus Surgical

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.